Protection of the gastroduodenal mucosa from the effects of diclofenac sodium: Role of highly selective vagotomy and misoprostol

World Journal of Surgery

Volumn 20, Issue 4, 1996, Pages 501-506

  Giannoukas, Athanasios D ^a,b   Baltoyiannis, Georgios ^a   Milonakis, Manolis ^a   Nastos, Dimitrios ^a   Papagikos, Lambros ^a   Kappas, Angelos M ^a   Fatouros, Michails ^a   Papadimitriou, Constantinos ^a   Cassioumis, Diamantis ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; DUODENUM MUCOSA; FEMALE; GASTRODUODENAL ULCER; HIGHLY SELECTIVE VAGOTOMY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; STOMACH MUCOSA; STOMACH PH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; COMBINED MODALITY THERAPY; DICLOFENAC; DOGS; DUODENUM; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; INJECTIONS, INTRAMUSCULAR; INTESTINAL MUCOSA; MALE; MISOPROSTOL; PEPTIC ULCER; TREATMENT OUTCOME; VAGOTOMY, PROXIMAL GASTRIC;

EID: 0029913185     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900079     Document Type: Article

References (51)

1. Varro, V., Csernay, L.: Experimental studies on the ulcerogenic effect of phenylbutazone. In Pathophysiology of Peptic Ulcer, S.C. Skoryna, editor. Montreal, McGill University Press, 1963, pp. 291-330
2. Cassioumis, D.: A study in the experimental peptic ulcer. M.D. thesis, Athens, Greece, 1966
3. Kirsner, B., Ford, H.: Phenylbutazone: effect on basal gastric secretion and the production of the gastroduodenal ulceration in dogs. Gastroenterology 29:18, 1955
4. Bugat, R., Thompson, M.R., Aures, D., et al.: Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology 71:754, 1976
5. Semble, E.L., Wu, W.C.: Antiinflammatory drugs and gastric mucosal damage. Semin. Arthritis Rheum. 16:271, 1987
6. Giannoukas, A.D.: The role of highly selective vagotomy and prostaglandins against the injurious effects of nonsteroidal antiinflammatory drugs on the gastroduodenal mucosa. M.D. thesis, Ioannina, Greece, 1992
7. Giannoukas, A.D., Blatoyannis, G., Nastos, D., Godevenos, D., Stefanou, D., Cassioumis, D.: The diclofenac sodium effects in the gastroduodenal mucosa. Hellenic J. Gastroenterol. 6(Suppl.):19, 1993
8. Nicoloff, D.: The effect of Indocid (indomethacin) on gastric secretion, parietal cell population and ulcer provocation in the dog. Gastroenterology 52:1111, 1967
9. Roth, S.H., Bennet, R.E.: Nonsteroidal antiinflammatory drug gastropathy. Arch. Intern. Med. 147:2093, 1987
10. Armstrong, C.T., Blower, A.L.: Nonsteroidal antiinflammatory drugs and life threatening complications of peptic ulceration. Gut 28:527, 1987
11. Somerville, K., Faulkner, G., Langman, M.: Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1:462, 1986
12. Collier, D.S., Pain, J.A.: Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26:359, 1985
13. Fries, J.F., Miller, S.R., Spitz, P.W., et al.: Toward an epidemiology of gastropathy associated with uonsteriodal antimflammatory drug use. Gastroenterology 96:647, 1989
14. Langman, M.J.S.: Adverse Drug Reaction Bulletin 120(Oct):448, 1986
15. Larkai, E.N., Smith, J.L., Lidsky, M.D., Graham, D.Y.: Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal antiinflammatory drug use. Am. J. Gastroenterol. 52:1153, 1987
16. Silvoso, G.R., Ivey, K.J., Butt, J.H., et al.: Incidence of gastric lesions in patients with rheumatoid disease on chronic aspirin therapy. Ann. Intern. Med. 91:517, 1979
17. Morris, A.D., Holt, S.D., Silvoso, G.R., et al.: Effect of antiinflammatory drug administration in patients with rheumatoid arthritis: an endoscopic assessment. Scand. J. Gastroenterol. 16:131, 1981
18. Skander, M.P., Rayan, F.P.: Nonsteroidal antiinflammatory drugs and pain free peptic ulceration in the elderly. B.M.J. 297:833, 1988
19. Soll, A.H., Kurata, J., McGuigan, I.E.: Ulcers, nonsteroidal antiinflammatory drugs and related matters. Gastroenterology 96(Suppl. 2):561, 1989
20. Caldwell, J.R., Roth, S.H., Wu, W.C., et al.: Sucralfate treatment of nonsteroidal antiinflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am. J. Med. 83(Suppl. 3B):74, 1987
21. Roth, S.H., Bennett, R.E., Mitchell, C.S., Hartman, R.J.: Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Arch. Intern. Med. 147:1798, 1987
22. Lanza, F.L., Aspinall, R.L., Swabb, E.A., et al.: Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mocosal injury to the stomach and duodenum. Gastroenterology 95:289, 1988
23. Ehsanullah, R.S.B., Page, M.C., Tildcsley, G., Wood, J.R.: NSAIDs-induced gastroduodenal damage: effect of ranitidine prophylaxis [abstract]. Gastroenterology 94:A111, 1988
24. Lanza, F., Robinson, M., Bowers, J., et al.: A multicenter double-blind comparison of ranitidine vs placebo in the prophylaxis of nonsteroidal antiinflammatory drug (NSAID) induced lesions in the gastric and duodenal mucosa [abstract]. Gastroenterology 94:A250, 1988
25. Jiranek, G.C., Kimmey, M.B., Saunders, D.R., Wilson, R.A., Shanahan, W., Silverstein, F.E.: Misprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Gastroenterology 96(Suppl. 2):656, 1989
26. Dozois, R.R., Kelly, K.A.: Gastric secretion and motility in duodenal ulcer: effect of current vagotomies. Surg. Clin. North Am. 56:1267, 1976
27. Greenall, M.J., Lyndon, P.J., Goligher, J.C., Johnston, D.: Long term effect of highly selective vagotomy on basal and maximal acid output in man. Gastroenterology 68:1421, 1975
28. Liavag, I., Ronald, M.A.: Seven-year follow-up of proximal gastric vagotomy: secretory studies. Scand. J Gastroenterol. 14:409, 1979
29. Natsikas, N.B., Konstantaras, C., Psarrakos, K.P., Kappas, A.M., Lazarides, D.P.. The effect of highly selective vagotomy on canine gastric mucosal blood flow. World J. Surg. 5:277, 1981
30. Schoen, R.T., Vender, R.J.: Mechanisms of noasteroidal antiinflammatory drug induced damage. Am. J. Med. 86:449, 1989
31. Miller, T.A.: Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am. J. Physiol. 245:G601, 1983
32. Fromm, D.: Drug-induced gastric mucosal injury. World J. Surg. 5:199, 1981
33. 2: an endoscopic study. Gastroenterology 86:339, 1984
34. Silverstein, F.E., Kimmey, M.B., Saunders, D.R., Levine, D.S.: Gastric protection by misoprostol against 1300 mg aspirin: an endoscopic study. Dig. Dis. Sci. 31:1375, 1986
35. Johnston, D.: Vagotomy. In Maingot's Abdominal Operations (9th ed.), S.I. Schwartz, H. Ellis, editors. London, Appleton & Lange, 1990, pp, 647-665
36. Dale, M.: Extra-pharmacopoeia. In (13th ed.), J. Reynolds, editor. London, Pharmaceutical Press, 1993
37. Williams, G.T.: The stomach: developmental and inflammatory conditions. In Oxford Textbook of Pathology, J. O'D. McGee, P.G. Isaacson, N.A. Wright, editors. Oxford, Oxford University Press, 1992, pp. 1149-1165
38. Sato, H., Guth, P.H., Grossman, M.I.: Role of food in gastointestinal ulceration produced by indomethacin in the rat. Gastroenterology. 83:210, 1982
39. Menasse, R., Hedwall, P.R., Kraetz, J., et al.: Pharmacological protpertis of diclofenac sodium and its metabolies. Scand. J. Rheumatol. 22:(Suppl.):5, 1978
40. Rainsford, K D., Willis, C.: Relationship of gastric mucosa damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production. Dig. Dis. Sci. 27:624, 1982
41. Chaudhury, T.K., Jacobson, E.D.: Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:58, 1978
42. Hawkey, C.J., Rampton, D.S.: Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease or treatment? Gastroenterology 89:1162, 1985
43. Graham, D.: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 96: 675, 1989
44. Schirmer, B.D.: Current status of proximal gastric vagotomy. Ann. Surg. 209:131, 1989
45. Johnston, D., Wilkinson, A.R.: Highly selective vagotomy without a drainage procedure in the treatment of duodenal ulcer. Br. J. Surg. 57:289, 1970
46. 99Tcm-HIDA before and after the procedure. Hellenic J. Gastroenterol. 1:123, 1988
47. Clarke, R.J, Alexander-Williams, J.: The effect of preserving antral innervation and of a pyloroplasty on gastric emptying after vagotomy in man. Gut 14:300, 1973
48. Smith, R.B., Edwards, J.P., Johnston, D.: Effect of vagotomy on exocrine pancreatic and biliary secretion in man Am. J. Surg. 141:40, 1981
49. Selling, J.A., Hogan, D.L., Koss, M.A., et al.: Human proximal versus distal duodenal bicarbonate secretion: effect of endogenous prostaglandins synthesis. Gastroenterology 88:A1580, 1985
50. Redfern, J.S., Feldman, M.: Role of endogenous prostaglandins in preventing gastrointestinal ulceration, induction of ulcers by antibodies to prostaglandins. Gastroenterology 96:596, 1989
51. 2. Gastroenterology 93:744, 1987